Speeding the time-to-clinic with Optimer®
New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…
How robust are Optimer-based affinity columns?
As part of the Biologics Europe digital conference our CTO, Dr David Bunka, was invited to present as part of Sartorius’ workshop in the ‘Protein Engineering, Protein & Antibody…
AptaBind: Enabling Improved Protein Purification with Aptamer-Mediated Affinity Chromatography (AMAC)
Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…